VITALCONNECT

In News

IRhythm grows heart monitoring leadership with $288M VitalConnect buy - MedTech Dive

MedTech Dive - Aug 10, 2026

iRhythm to buy VitalConnect for $287.5M after Street-beating Q2 - MassDevice

MassDevice - Aug 07, 2026

iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform - Zacks Investment Research

Zacks Investment Research - Aug 14, 2026

iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform - TradingView

TradingView - Aug 14, 2026

iRhythm to Acquire VitalConnect for $287.5M, Expanding Cardiac Monitoring Platform - HLTH

HLTH - Aug 11, 2026

iRhythm to acquire rival cardiac monitoring company for $288M - Cardiovascular Business

Cardiovascular Business - Aug 10, 2026

IRhythm to Gain From VitalConnect Deal, Rising Margins, Oppenheimer Says - Moomoo

Moomoo - Aug 10, 2026

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform - HIT Consultant

HIT Consultant - Aug 10, 2026

iRhythm advances cardiac monitoring provision with $287.5m VitalConnect acquisition - Medical Device Network

Medical Device Network - Aug 07, 2026

iRhythm Expands MCT Footprint with VitalConnect Acquisition - Cardiac Wire

Cardiac Wire - Aug 10, 2026

Post-Cyberattack, iRhythm to Acquire VitalConnect for $287.5M - mddionline.com

mddionline.com - Aug 07, 2026

iRhythm Holdings Acquiring VitalConnect for $287.5 Million - Barron's

Barron's - Aug 07, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment